Pyxis Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	8.92	19.47	9.66	179.29	274.74	8.08
Short-Term Investments	67.34	107.46	109.63	-	-	-
Cash & Short-Term Investments	76.26	126.93	119.3	179.29	274.74	8.08
Cash Growth	-47.34%	6.40%	-33.46%	-34.74%	3300.19%	-58.96%
Other Receivables	-	-	-	0.6	-	-
Receivables	-	-	-	0.6	-	-
Prepaid Expenses	5.35	0.76	1.01	1.31	1.76	0.01
Restricted Cash	1.47	1.47	1.47	1.47	1.47	-
Other Current Assets	-	3.28	2.82	3.94	0.7	0.02
Total Current Assets	83.07	132.44	124.6	186.61	278.67	8.1
Property, Plant & Equipment	20.1	22.14	24.81	24.77	1.24	1.94
Other Intangible Assets	2.43	2.6	24.31	-	-	-
Other Long-Term Assets	-	-	-	-	0.11	0.11
Total Assets	105.6	157.18	173.73	211.38	280.02	10.15
Accounts Payable	9.76	4.86	3.9	7.1	11.95	1.08
Accrued Expenses	8	10.73	12.62	23.45	6.33	1.88
Current Portion of Leases	1.63	1.45	1.23	-	0.17	0.62
Current Unearned Revenue	-	-	7.66	-	-	-
Other Current Liabilities	-	0.64	0.36	1.09	0.27	0.12
Total Current Liabilities	19.38	17.68	25.76	31.63	18.71	3.69
Long-Term Leases	17.44	18.75	20.1	18.92	-	0.17
Long-Term Deferred Tax Liabilities	-	-	2.16	-	-	-
Total Liabilities	36.83	36.43	48.02	50.56	18.71	3.85
Common Stock	0.06	0.06	0.05	0.03	0.03	0
Additional Paid-In Capital	493.72	484.08	411.82	373.23	353	0.1
Retained Earnings	-425.07	-363.56	-286.23	-212.44	-91.72	-15.74
Comprehensive Income & Other	0.07	0.17	0.06	-	-	-
Total Common Equity	68.78	120.75	125.7	160.82	261.31	-15.65
Shareholders' Equity	68.78	120.75	125.7	160.82	261.31	6.3
Total Liabilities & Equity	105.6	157.18	173.73	211.38	280.02	10.15
Total Debt	19.07	20.2	21.33	18.92	0.17	0.78
Net Cash (Debt)	57.18	106.73	97.97	160.37	274.57	7.3
Net Cash Growth	-53.99%	8.95%	-38.91%	-41.59%	3661.23%	-62.90%
Net Cash Per Share	0.93	1.83	2.46	4.85	32.33	7.08
Filing Date Shares Outstanding	62.26	61.59	58.13	36.83	32.22	1.29
Total Common Shares Outstanding	62.15	59.97	44.75	34.96	32.17	1.29
Working Capital	63.69	114.76	98.85	154.98	259.97	4.41
Book Value Per Share	1.11	2.01	2.81	4.60	8.12	-12.13
Tangible Book Value	66.35	118.15	101.4	160.82	261.31	-15.65
Tangible Book Value Per Share	1.07	1.97	2.27	4.60	8.12	-12.13
Machinery	-	4.19	4.52	3.28	1.9	1.36
Construction In Progress	-	-	-	9.18	-	-
Leasehold Improvements	-	10.74	10.96	0.53	0.23	0.21

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q